Observing severe dengue cases in critical care in Villavicencio, Colombia.

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients admitted to critical care units with severe dengue, particularly during epidemic outbreaks. It aims to gather data on the clinical characteristics, treatment approaches, and outcomes of these patients, as current guidelines lack performance data specific to the local context. The study will monitor factors such as organ dysfunction, hemorrhagic events, and capillary leak, which are critical in predicting mortality. By analyzing these cases, the study seeks to improve understanding and management of severe dengue in intensive care settings.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients admitted at a critical care unit with a diagnose of dengue either clinical or by a positive serology or molecular diagnostic methods.

Exclusion Criteria:

* Patients with a post admission diagnosis different than dengue either clinical or by a negative serology.

Where it's running

• Clinica Primavera
  Villavicencio, Meta, Colombia Recruiting
• Hospital Departamental de Villavicencio
  Villavicencio, Meta, Colombia Recruiting

Study contacts

• Principal investigator: Norton Perez-Gutierrez, MD — Cooperative University of Colombia
• Study coordinator: Norton Perez-Gutierrez, MD
• Email: norton.perez@hotmail.com
• Phone: 6086660154

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Innovative strategies to understand and combat severe dengue

  This study is trying to find out what makes dengue infections more severe by looking at blood samples from patients in areas where dengue is common, to help improve treatment and prevention.

  Recruiting at 2 sites Karolinska Institutet · Guatemala City and 1 other locations · NCT06751836

• Dexamethasone for dengue with warning signs

  This trial will test whether dexamethasone helps people with severe dengue who have warning signs.

  Recruiting at 2 sites Chulalongkorn University · Bangkok and 1 other locations · NCT05631405

• Dengue virus challenge in healthy adults to study immune responses

  Researchers will infect healthy adults with a weakened dengue virus to see how their bodies respond and how past exposure affects the reaction.

  Recruiting Phase 1 National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07706686

• Gut leakage in dengue: is the intestinal barrier affected during infection?

  Researchers are studying whether dengue infection disrupts the gut barrier and if that contributes to severe disease in adults with dengue who are in hospital.

  Recruiting University of Oxford · Chittagong, Chattogram Division · NCT07602920

• CP-COV03 versus placebo for adults with dengue or dengue-like illness

  This trial tests whether taking CP-COV03 for seven days helps adults with dengue (or dengue-like illnesses) recover faster and lower their viral levels compared with a placebo.

  Recruiting at 2 sites Phase 2/3 Hyundai Bioscience Co., Ltd. · Hanoi and 1 other locations · NCT07576868

• Community spread of multiple infectious diseases in Cambodia from a One Health perspective

  This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.

  Recruiting Institut Pasteur du Cambodge · Phnom Penh, Phnom Penh · NCT07358910

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.